NeuroOne Medical Technologies Corporation Rings the Nasdaq Stock Market Closing Bell
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on the development and commercialization of minimally invasive and high-definition/high-precision solutions for epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic back pain, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Dave Rosa, CEO, rings the Closing Bell.